The Efficacy of Cognitive Behavioral Therapy (CBT) in Treating Treatment-Resistant Depression: Mechanisms and Long-Term Outcomes
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 45
فایل این مقاله در 14 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MPHRJ-2-6_004
تاریخ نمایه سازی: 14 مرداد 1405
چکیده مقاله:
Background: Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately ۳۰% of individuals with major depressive disorder who fail to respond to conventional antidepressant pharmacotherapy. Cognitive Behavioral Therapy (CBT) has emerged as a promising intervention for this population, yet the specific mechanisms and long-term efficacy remain incompletely understood. Objective: This study systematically examines the efficacy of CBT in treating TRD, investigating psychological and neurobiological mechanisms of change and evaluating long-term outcomes. Methods: A comprehensive review was conducted of randomized controlled trials, meta-analyses, and key observational studies published between ۲۰۰۰ and ۲۰۲۵, identified from PubMed, PsycINFO, and Cochrane Library databases. Special attention was given to studies examining CBT as an augmentation strategy, sudden gains in treatment response, and neural correlates of therapeutic change. Results: Robust evidence supports CBT as an effective augmentation strategy for TRD, with effect sizes comparable to pharmacological augmentation approaches (ES = ۱.۵۸, ۹۵% CI: ۱.۰۹–۲.۰۷). Psychological flexibility emerged as a key mechanism predicting long-term outcomes at ۱۲-month follow-up. Neuroimaging findings reveal both treatment-responsive prefrontal and parietal regions and treatment-resistant cerebellar regions, suggesting that CBT may not uniformly normalize all neural abnormalities. Long-term relapse rates among TRD patients receiving CBT augmentation range from ۲۵-۵۰% at ۱۲ months, with the greatest durability observed in those who achieve sudden therapeutic gains early in treatment. Conclusion: CBT constitutes an essential component of the TRD treatment arsenal, offering durable benefits beyond pharmacotherapy alone. Future research must prioritize standardized TRD definitions, biomarker-driven personalization, and scalable delivery models to optimize clinical implementation.
کلیدواژه ها:
نویسندگان
Sunay Güngör
Gümüşhane University, Faculty of Literature, Department of Psychology, Gümüşhane- TURKIYE
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :